LSD History & Microdosing


LSD, or lysergic acid diethylamide, is a hallucinogenic drug that was first synthesized a Swiss scientist in the 1930s. During the Cold War, the CIA conducted clandestine experiments with LSD (and other drugs) for mind control, information gathering and other purposes. Over time, the drug became a symbol of the 1960s counterculture, eventually joining other […]

Top 6 Most Popular Psilocybin Mushroom Species In Canada

Copy of Untitled 30

Psilocybin mushrooms are a hallucinogen that people in Canada can use to feel relaxed, have an increased sense of well-being, and experience visual effects. This article features the top six most popular psilocybin mushroom species in Canada. These types of mushrooms are also known as magic mushrooms or shrooms. Defining Magic Mushrooms Before we get into the […]

What does it feel like to trip on mushrooms?

Copy of Untitled 26

The psychoactive properties of mushrooms are not well understood, but they have been used for centuries. They can induce a euphoric and/or hallucinogenic state that will differ from person to person. Some people may be able to experience the effects of the mushroom, while others may find it too intense or overwhelming. Mushrooms are typically […]

Top 5 common myths surrounding magic mushrooms

Copy of Untitled 8

For those of you who have never heard the word “psychedelic” before, it’s a term used to describe any mind-altering substance that produces sensory and perceptual changes. Common psychedelics include LSD, psilocybin (magic mushrooms), mescaline, and DMT. These substances are often used for medicinal purposes, such as treating depression or addiction, but there is still […]

The Link Between Psilocybin and Mental Health

Copy of Untitled

Psilocybin is a psychedelic compound that can produce altered states of consciousness, including euphoria and hallucinations. It’s the main active ingredient in “magic mushrooms.” A study published in the Journal of Psychopharmacology found that psilocybin-assisted therapy could help people with treatment-resistant depression. The trial involved 29 patients who had not improved after at least two […]